Unique Ingredient Identifier T5L8T28FGP is listed as a ingredient substance
RN | 8042-47-5 |
EC | 232-455-8 |
NCIT | C29264 |
RXCUI | 6972 |
UNII T5L8T28FGP MINERAL OIL is commonly included in medications in the following forms.
Route | Dosage Form | Potency |
---|---|---|
AURICULAR (OTIC) | OINTMENT | NA |
AURICULAR (OTIC) | SUSPENSION | 0.5 % |
DENTAL | PASTE | 457.95 MG |
OPHTHALMIC | OINTMENT | 59.5 % |
OPHTHALMIC | SUSPENSION | 0.1 % |
ORAL | CAPSULE | 60.08 MG |
ORAL | CAPSULE, SUSTAINED ACTION | 50 MG |
ORAL | DROPS | NA |
ORAL | TABLET | 50 MG |
ORAL | TABLET, COATED | 1.3 MG |
ORAL | TABLET, DELAYED ACTION, ENTERIC COATED | 5.67 MG |
ORAL | TABLET, FILM COATED | NA |
ORAL | TABLET, SUSTAINED ACTION | NA |
TOPICAL | AEROSOL, SPRAY | NA |
TOPICAL | CREAM | 23.63 %W/W |
TOPICAL | CREAM, AUGMENTED | 50.62 %W/W |
TOPICAL | CREAM, EMULSION, SUSTAINED RELEASE | 50.6 %W/W |
TOPICAL | EMULSION, CREAM | 40 %W/W |
TOPICAL | EMULSION, LOTION | 20 %W/W |
TOPICAL | GEL | 2.5 %W/W |
TOPICAL | LOTION | 20 %W/W |
TOPICAL | OIL | 42 %W/W |
TOPICAL | OINTMENT | 97.95 %W/W |
TOPICAL | PASTE | 47.5 %W/W |
TOPICAL | PATCH | NA |
TOPICAL | SPRAY | 45.95 %W/W |
TOPICAL | SUPPOSITORY | NA |
TOPICAL | SUSPENSION | 82 %W/W |
TRANSDERMAL | FILM | 11.42 MG |
TRANSDERMAL | FILM, CONTROLLED RELEASE | 34 MG |
TRANSDERMAL | PATCH, CONTROLLED RELEASE | 1.52 MG |
VAGINAL | CREAM, EMULSION, SUSTAINED RELEASE | 7 % |
VAGINAL | EMULSION, CREAM | 15 % |
VAGINAL | GEL | 4.73 % |
VAGINAL | SUPPOSITORY | 3 %W/W |